Healthpeak Properties, Inc. (DOC)
$500 per Month in Passive Income – Invest This Much in These 3 Monthly Dividend Stocks
$500 per month may seem small, but it's not a trivial amount and can snowball your portfolio quickly.
Why Healthpeak Properties Is Of Interest To Me At This Price
Healthpeak Properties is rated a "Buy," driven by undervaluation and a 7.16% yield. DOC's strategic shift from SHOP to labs and outpatient medical buildings increases capital intensity and AFFO volatility, but current pricing discounts these risks. I expect limited AFFO growth (0-2%) and earnings compression, positioning DOC as a cash-generating, low-growth REIT.
2 Reliable And Undervalued Dividends For Passive Income
Verizon is executing a turnaround, leveraging network infrastructure, fiber expansion, and cost efficiencies to drive subscriber growth and sustainable cash flow. VZ remains undervalued at a forward P/E of 10x versus its historical 13x, with a 5.7% dividend yield and double-digit total return potential. Healthpeak Properties offers a 7% yield, robust outpatient and senior housing growth, and a catalyst from the Janus Living IPO.
Healthpeak Is Unlocking Its Senior Housing Value
Healthpeak is undervalued, as its senior housing assets are not fully reflected in its stock price. The Janus Living IPO will force the market to recognize DOC's $4.25B senior housing value, above its $3B book value. JAN's IPO is well-subscribed, targeting a $19/share midpoint and a 25–30x AFFO multiple, validating higher asset quality.
Healthpeak Properties, Inc. (NYSE:DOC) Receives Average Rating of “Hold” from Brokerages
Shares of Healthpeak Properties, Inc. (NYSE: DOC - Get Free Report) have been given an average recommendation of "Hold" by the thirteen brokerages that are currently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month
These S&P 500 Dividend Stocks Are Quietly Crushing the Index — And Paying You Monthly
The S&P 500 index includes a broad variety of companies. Some of them pay little to no dividends, while others offer decent yields.
Healthpeak Properties: Sell-Off Has Gone Too Far, I'm Buying This High-Yield Dividend REIT (Upgrade)
Healthpeak Properties is upgraded to Strong Buy, driven by resilient financials, high yield, and recovery potential despite lab segment weakness. DOC offers a sustainable 7.3% annualized monthly dividend yield with a conservative ~72% AFFO payout ratio, supporting both buybacks and acquisitions while their asset recycling continues. Management anticipates a pivotal 2026, with portfolio rebalancing, $1 billion in asset sales, recapitalizations, and loan repayments, with early signs of a lab segment inflection point.
2 REITs That Look Attractive in a Stable Rate Environment
The Trump administration may have unintentionally thrown a bone to the real estate investment trust (REIT) industry. President Trump's nomination of Kevin Warsh to be the next chair of the Federal Reserve provides more clarity, and more importantly, predictability to the course of rate cuts in 2026.
Healthpeak Properties, Inc. (DOC) Q4 2025 Earnings Call Transcript
Healthpeak Properties, Inc. (DOC) Q4 2025 Earnings Call Transcript
Healthpeak's Pivot: A Masterclass In Value Destruction (Rating Downgrade)
Healthpeak Properties (DOC) is rated HOLD due to poor capital allocation, underperformance, and execution risk despite an attractive, well-covered 7% dividend yield. Recent strategic pivot includes spinning off senior housing assets into Janus Living, but external management and dual-CEO structure introduce significant execution risk. DOC trades at a 15–20% discount to NAV, failed to achieve targeted FFO growth and stability, and underperformed VNQ by nearly 60% since 2019.
Healthpeak Q4 FFO Beats Estimates, Same-Store NOI Rises Y/Y
DOC tops Q4 FFO and revenue estimates, driven by same-store NOI growth, while outlining portfolio reshaping and new strategic initiatives.
Healthpeak (DOC) Beats Q4 FFO and Revenue Estimates
Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.47 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to FFO of $0.46 per share a year ago.
